1 Death of baby (up to discharge) |
20 |
2680 |
Risk Ratio (M‐H, Random, 95% CI) |
0.73 [0.54, 0.98] |
1.1 < 32‐34 weeks gestation |
13 |
2108 |
Risk Ratio (M‐H, Random, 95% CI) |
0.71 [0.52, 0.96] |
1.2 > 32‐34 weeks gestation |
3 |
237 |
Risk Ratio (M‐H, Random, 95% CI) |
5.18 [0.25, 105.47] |
1.3 Mixed gestation |
4 |
335 |
Risk Ratio (M‐H, Random, 95% CI) |
0.80 [0.09, 7.04] |
2 Death or neurodevelopmental impairment in early years |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
2.1 < 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
2.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
2.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
3 Severe intraventricular haemorrhage (IVH grades 3, 4) |
10 |
2058 |
Risk Ratio (M‐H, Random, 95% CI) |
0.94 [0.63, 1.39] |
3.1 < 32‐34 weeks gestation |
9 |
1972 |
Risk Ratio (M‐H, Random, 95% CI) |
0.95 [0.64, 1.42] |
3.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
3.3 Mixed gestation |
1 |
86 |
Risk Ratio (M‐H, Random, 95% CI) |
0.58 [0.05, 6.11] |
4 Intraventricular haemorrhage (IVH, all grades) |
15 |
2333 |
Risk Ratio (M‐H, Random, 95% CI) |
0.83 [0.70, 0.99] |
4.1 < 32‐34 weeks gestation |
11 |
1988 |
Risk Ratio (M‐H, Random, 95% CI) |
0.76 [0.56, 1.02] |
4.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
4.3 Mixed gestation |
4 |
345 |
Risk Ratio (M‐H, Random, 95% CI) |
0.66 [0.38, 1.16] |
5 Periventricular leukomalacia (PVL) |
4 |
1544 |
Risk Ratio (M‐H, Random, 95% CI) |
0.58 [0.26, 1.30] |
5.1 < 32‐34 weeks gestation |
4 |
1544 |
Risk Ratio (M‐H, Random, 95% CI) |
0.58 [0.26, 1.30] |
5.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
5.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
6 Chronic lung disease (CLD) ‐ oxygen supplement at 36 weeks (corrected for gestation) |
6 |
1644 |
Risk Ratio (M‐H, Random, 95% CI) |
1.04 [0.94, 1.14] |
6.1 < 32‐34 weeks gestation |
6 |
1644 |
Risk Ratio (M‐H, Random, 95% CI) |
1.04 [0.94, 1.14] |
6.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
6.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
7 Maternal blood loss of 500 mL or greater |
2 |
180 |
Risk Ratio (M‐H, Random, 95% CI) |
1.14 [0.07, 17.63] |
7.1 < 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
7.2 > 32‐34 weeks gestation |
1 |
86 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
7.3 Mixed gestation |
1 |
94 |
Risk Ratio (M‐H, Random, 95% CI) |
1.14 [0.07, 17.63] |
8 Intraventricular haemorrhage (IVH, grades 1 & 2) |
9 |
1968 |
Risk Ratio (M‐H, Random, 95% CI) |
0.72 [0.51, 1.02] |
8.1 < 32‐34 weeks gestation |
8 |
1882 |
Risk Ratio (M‐H, Random, 95% CI) |
0.68 [0.45, 1.03] |
8.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
8.3 Mixed gestation |
1 |
86 |
Risk Ratio (M‐H, Random, 95% CI) |
0.89 [0.37, 2.18] |
9 Necrotising enterocolitis (NEC) confirmed by X‐ray or laparotomy) |
11 |
2010 |
Risk Ratio (M‐H, Random, 95% CI) |
0.91 [0.64, 1.28] |
9.1 < 32‐34 weeks gestation |
10 |
1916 |
Risk Ratio (M‐H, Random, 95% CI) |
0.86 [0.60, 1.22] |
9.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
9.3 Mixed gestation |
1 |
94 |
Risk Ratio (M‐H, Random, 95% CI) |
2.84 [0.58, 13.92] |
10 Respiratory Distress Syndrome (RDS) |
7 |
457 |
Risk Ratio (M‐H, Random, 95% CI) |
1.09 [0.86, 1.38] |
10.1 < 32‐34 weeks gestation |
3 |
165 |
Risk Ratio (M‐H, Random, 95% CI) |
1.21 [0.64, 2.27] |
10.2 > 32‐34 weeks gestation |
1 |
86 |
Risk Ratio (M‐H, Random, 95% CI) |
0.79 [0.19, 3.30] |
10.3 Mixed gestation |
3 |
206 |
Risk Ratio (M‐H, Random, 95% CI) |
1.32 [0.52, 3.36] |
11 Respiratory support (ventilator or CPAP) |
6 |
325 |
Risk Ratio (M‐H, Random, 95% CI) |
0.95 [0.77, 1.16] |
11.1 < 32‐34 weeks gestation |
5 |
220 |
Risk Ratio (M‐H, Random, 95% CI) |
0.96 [0.78, 1.18] |
11.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
11.3 Mixed gestation |
1 |
105 |
Risk Ratio (M‐H, Random, 95% CI) |
0.57 [0.16, 2.09] |
12 Duration of respiratory support (in days) |
1 |
42 |
Mean Difference (IV, Random, 95% CI) |
‐0.60 [‐3.04, 1.84] |
12.1 < 32‐34 weeks gestation |
1 |
42 |
Mean Difference (IV, Random, 95% CI) |
‐0.60 [‐3.04, 1.84] |
12.2 > 32‐34 weeks gestation |
0 |
0 |
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
12.3 Mixed gestation |
0 |
0 |
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
13 Surfactant treatment (for severe RDS) |
3 |
145 |
Risk Ratio (M‐H, Random, 95% CI) |
0.80 [0.50, 1.28] |
13.1 < 32‐34 weeks gestation |
3 |
145 |
Risk Ratio (M‐H, Random, 95% CI) |
0.80 [0.50, 1.28] |
13.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
13.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
14 Treatment for Patent Ductus Arteriosus (PDA) (medical and/or surgical) |
10 |
2046 |
Risk Ratio (M‐H, Random, 95% CI) |
1.12 [0.99, 1.26] |
14.1 < 32‐34 weeks gestation |
9 |
1952 |
Risk Ratio (M‐H, Random, 95% CI) |
1.12 [0.99, 1.26] |
14.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
14.3 Mixed gestation |
1 |
94 |
Risk Ratio (M‐H, Random, 95% CI) |
1.14 [0.24, 5.34] |
15 Treatment for Retinopathy of Prematurity (RoP) |
8 |
1827 |
Risk Ratio (M‐H, Random, 95% CI) |
0.83 [0.62, 1.12] |
15.1 < 32‐34 weeks gestation |
8 |
1827 |
Risk Ratio (M‐H, Random, 95% CI) |
0.83 [0.62, 1.12] |
15.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
15.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
16 Hyperbilirubinemia (treated by phototherapy) |
8 |
495 |
Risk Ratio (M‐H, Random, 95% CI) |
1.05 [0.95, 1.16] |
16.1 < 32‐34 weeks gestation |
3 |
114 |
Risk Ratio (M‐H, Random, 95% CI) |
1.01 [0.91, 1.11] |
16.2 > 32‐34 weeks gestation |
2 |
123 |
Risk Ratio (M‐H, Random, 95% CI) |
0.73 [0.38, 1.41] |
16.3 Mixed gestation |
3 |
258 |
Risk Ratio (M‐H, Random, 95% CI) |
1.17 [0.93, 1.47] |
17 Inotropics for low blood pressure |
5 |
250 |
Risk Ratio (M‐H, Random, 95% CI) |
0.37 [0.17, 0.81] |
17.1 < 32‐34 weeks gestation |
5 |
250 |
Risk Ratio (M‐H, Random, 95% CI) |
0.37 [0.17, 0.81] |
17.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
17.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
18 Low Apgar as defined by trialists (generally < 8 at 5 mins) |
4 |
1721 |
Risk Ratio (M‐H, Random, 95% CI) |
1.07 [0.70, 1.63] |
18.1 < 32‐34 weeks gestation |
3 |
1637 |
Risk Ratio (M‐H, Random, 95% CI) |
1.01 [0.62, 1.62] |
18.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
18.3 Mixed gestation |
1 |
84 |
Risk Ratio (M‐H, Random, 95% CI) |
1.32 [0.53, 3.31] |
19 Blood transfusion in infant |
11 |
2280 |
Risk Ratio (M‐H, Random, 95% CI) |
0.66 [0.50, 0.86] |
19.1 < 32‐34 weeks gestation |
8 |
1995 |
Risk Ratio (M‐H, Random, 95% CI) |
0.64 [0.47, 0.87] |
19.2 > 32‐34 weeks gestation |
1 |
86 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
19.3 Mixed gestation |
2 |
199 |
Risk Ratio (M‐H, Random, 95% CI) |
0.67 [0.26, 1.74] |
20 Volume of blood transfused (mL) |
1 |
72 |
Mean Difference (IV, Random, 95% CI) |
‐6.0 [‐26.11, 14.11] |
20.1 < 32‐34 weeks gestation |
1 |
72 |
Mean Difference (IV, Random, 95% CI) |
‐6.0 [‐26.11, 14.11] |
20.2 > 32‐34 weeks gestation |
0 |
0 |
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
20.3 Mixed gestation |
0 |
0 |
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
21 Late sepsis (after 3 days or as defined by trialists) |
10 |
2017 |
Risk Ratio (M‐H, Random, 95% CI) |
0.79 [0.56, 1.10] |
21.1 < 32‐34 weeks gestation |
9 |
1923 |
Risk Ratio (M‐H, Random, 95% CI) |
0.76 [0.52, 1.11] |
21.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
21.3 Mixed gestation |
1 |
94 |
Risk Ratio (M‐H, Random, 95% CI) |
0.87 [0.43, 1.79] |
22 Hydrocephalus |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
22.1 < 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
22.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
22.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
23 Temperature < 36.0oC within 1 hour of birth |
1 |
86 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
23.1 < 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
23.2 > 32‐34 weeks gestation |
1 |
86 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
23.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
24 Hb within 1st 24 hour of birth (g/dL) |
1 |
42 |
Mean Difference (IV, Random, 95% CI) |
0.80 [‐0.02, 1.62] |
24.1 < 32‐34 weeks gestation |
1 |
42 |
Mean Difference (IV, Random, 95% CI) |
0.80 [‐0.02, 1.62] |
24.2 > 32‐34 weeks gestation |
0 |
0 |
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
24.3 Mixed gestation |
0 |
0 |
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
25 Mean arterial blood pressure in early hours after birth (mm Hg) |
4 |
208 |
Mean Difference (IV, Random, 95% CI) |
2.87 [1.09, 4.64] |
25.1 < 32‐34 weeks gestation |
4 |
208 |
Mean Difference (IV, Random, 95% CI) |
2.87 [1.09, 4.64] |
25.2 > 32‐34 weeks gestation |
0 |
0 |
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
25.3 Mixed gestation |
0 |
0 |
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
26 Length of infant stay in NICU |
0 |
0 |
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
26.1 < 32‐34 weeks gestation |
0 |
0 |
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
26.2 > 32‐34 weeks gestation |
0 |
0 |
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
26.3 Mixed gestation |
0 |
0 |
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
27 Home oxygen |
2 |
101 |
Risk Ratio (M‐H, Random, 95% CI) |
0.47 [0.06, 3.72] |
27.1 < 32‐34 weeks gestation |
2 |
101 |
Risk Ratio (M‐H, Random, 95% CI) |
0.47 [0.06, 3.72] |
27.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
27.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
28 Neurodevelopmental impairment at age two to three years (Baileys 11 MDI < 70) |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
28.1 < 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
28.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
28.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
29 Severe visual impairment |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
29.1 < 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
29.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
29.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
30 Cerebral palsy (CP) |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
30.1 < 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
30.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
30.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
31 Manual removal of placenta (denominator = vaginal births) |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
31.1 < 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
31.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
31.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
32 Prolonged third stage (> 30 minutes) (denominator = vaginal births) |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
32.1 < 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
32.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
32.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
33 Blood transfusion for mother |
1 |
1176 |
Risk Ratio (M‐H, Random, 95% CI) |
0.67 [0.36, 1.24] |
33.1 < 32‐34 weeks gestation |
1 |
1176 |
Risk Ratio (M‐H, Random, 95% CI) |
0.67 [0.36, 1.24] |
33.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
33.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
34 Postpartum infection in mother |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
34.1 < 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
34.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
34.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
35 Rhesus isoimmunisation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
35.1 < 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
35.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
35.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
36 Psychological well being in mother |
0 |
0 |
Std. Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
36.1 < 32‐34 weeks gestation |
0 |
0 |
Std. Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
36.2 > 32‐34 weeks gestation |
0 |
0 |
Std. Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
36.3 Mixed gestation |
0 |
0 |
Std. Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
37 Bonding |
0 |
0 |
Std. Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
37.1 < 32‐34 weeks gestation |
0 |
0 |
Std. Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
37.2 > 32‐34 weeks gestation |
0 |
0 |
Std. Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
37.3 Mixed gestation |
0 |
0 |
Std. Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
38 Breastfeeding initiation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
38.1 < 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
38.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
38.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
39 Fully breastfed or mixed feeding at infant discharge |
1 |
94 |
Risk Ratio (M‐H, Random, 95% CI) |
1.11 [1.00, 1.23] |
39.1 < 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
39.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
39.3 Mixed gestation |
1 |
94 |
Risk Ratio (M‐H, Random, 95% CI) |
1.11 [1.00, 1.23] |
40 Maternal anxiety |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
40.1 < 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
40.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
40.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
41 Mothers' views |
0 |
0 |
Std. Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
41.1 < 32‐34 weeks gestation |
0 |
0 |
Std. Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
41.2 > 32‐34 weeks gestation |
0 |
0 |
Std. Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
41.3 Mixed gestation |
0 |
0 |
Std. Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |